Report from the annual general meeting of IRLAB Therapeutics AB
IRLAB Therapeutics AB held its Annual General Meeting on May 6, 2021. In order to counteract the virus that causes covid-19, the Annual General Meeting was held solely by postal voting without physical participation. The following main resolutions were resolved upon at the Annual General Meeting. Disposition of the company´s results The AGM resolved that the profit and loss account and the balance sheet produced to the Annual General Meeting for the fiscal year 2020, be duly adopted. The disposition of the company’s results proposed by the Board of Directors’ was adopted by the